1-dodecyloxy-butan-2-ol | 14863-64-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-dodecyloxy-butan-2-ol
• 英文别名: 1-Dodecoxybutan-2-ol
• CAS: 14863-64-0
• 化学式: C₁₆H₃₄O₂
• 分子量: 258.445
• InChiKey: MZKCQCAOCJKGNQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  18
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENT
  申请人：Deshpande Milind

  公开号：US20160016986A1

  公开（公告）日：2016-01-21

  5′-Deuterated nucleosides and nucleotides and modifications thereof are provided for use in medical therapies, including as antiviral, anti-tumor and anti-neoplastic agents. In one embodiment, compounds, methods and uses are provided for the treatment of hepatitis C, RSV, HSV and other viral diseases in a host, including a human.

  提供了用于医疗疗法的5'-氘代核苷和核苷酸以及其修饰，包括作为抗病毒、抗肿瘤和抗肿瘤剂。在一个实施例中，提供了化合物、方法和用途，用于治疗丙型肝炎、RSV、HSV和其他病毒性疾病在宿主中，包括人类。
• ASCORBIC ACID DERIVATIVE OR SALT THEREOF, PRODUCTION METHOD THEREOF, AND COSMETIC
  申请人：Yoshioka Masato

  公开号：US20110059034A1

  公开（公告）日：2011-03-10

  Disclosed is an ascorbic acid derivative or a salt thereof wherein at least one of hydrogen atoms in hydroxy groups at the 2-position and the 3-position of ascorbic acid is substituted by R—O—CH 2 —CH(OH)—CH 2 —, R—O—CH 2 —CH(CH 2 OH)—, R—CH(CH 2 OH)—, R—CH(OH)—CH 2 — (wherein R represents an alkyl group, an alkenyl group or a phenyl group), or a hydroxycyclohexyl group. Also disclosed is a method for producing an ascorbic acid derivative or a salt thereof, which is characterized by reacting ascorbic acid with an epoxy compound such as an alkyl glycidyl ether, an epoxy alkane or an alicyclic epoxy.

  本发明涉及一种抗坏血酸衍生物或其盐，其中抗坏血酸的2-位和3-位羟基中的至少一个氢原子被R-O-CH2-CH（OH）- -，R-O- -CH（ OH）-，R-CH（ OH）-，R-CH（OH）- -（其中R代表烷基，烯基或苯基）或羟基环己基取代。本发明还公开了一种制备抗坏血酸衍生物或其盐的方法，其特征在于将抗坏血酸与环氧化合物（例如烷基环氧乙醚，环氧烷或脂环烷环氧）反应。
• FLÜSSIGKRISTALLINES MEDIUM ENTHALTEND FLUORIERTE INDANVERBINDUNG
  申请人：Merck Patent GmbH

  公开号：EP1673418B1

  公开（公告）日：2015-08-12
• WATER-IN-OIL EMULSION SYSTEM AND PREPARATION PROCESS THEREOF
  申请人：Zhang Haizhou

  公开号：US20100310617A1

  公开（公告）日：2010-12-09

  The present invention relates to a water-in-oil system, which comprises 1.5-9 wt. % of hydrophobic silica, 0.1-5 wt. % of a water-in-oil emulsifier, 10-40 wt. % of an oil phase, with the content of the oil phase not including the hydrophobic silica and water-in-oil emulsifier therein, and 55-85 wt % of a water phase; with the proviso that said hydrophobic silica is not AEROSIL® RY200 hydrophobic fumed silica, and it is excluded the formulation comprising the components of: polyoxyalkylene modified polysiloxane SH3775E, a compound of the following formula (I) and hydrophobic fumed silica AEROSIL® R812, in which the weight ratio of SH3775E to the compound of formula (I) is 05, and the weight ratio of the sum of SH3775E and the compound of formula (I) to hydrophobic fumed silica AEROSIL® R812 is also 05.
• US8163939B2
  申请人：——

  公开号：US8163939B2

  公开（公告）日：2012-04-24